Showing results (31-40 of 72) with videos related to
Sort By:
Pageof 8
The American Journal of Medicine|December 22, 2019
Safety and Efficacy of High-Dose Unfractionated Heparin Versus High-Dose Enoxaparin for Venous Thromboembolism Prevention in Morbidly Obese Hospitalized PatientsS Walker Mason, Alexandra Barber, Emily Jones, et al.International Journal of Spine Surgery|September 28, 2020
An Evidence-Based Algorithm for Determining Venous Thromboembolism Prophylaxis After Degenerative Spinal SurgeryJoshua A Shapiro, Matthew R Stillwagon, Alexander G Padovano, et al.Research and Practice in Thrombosis and Haemostasis|March 18, 2021
Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factorsHarish Eswaran, Jamie A Jarmul, Amy W Shaheen, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 28, 2004
Percutaneous coronary intervention in a patient with immune thrombocytopenia purpuraGeorge A Stouffer, Jana Hirmerova, Stephan Moll, et al.Leukemia & Lymphoma|April 11, 2017
Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohortDamon E Houghton, Nigel S Key, Neil A Zakai, et al.The American Journal of Medicine|September 4, 2012
Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxisTracy Y Wang, Emily F Honeycutt, Victor F Tapson, et al.Thrombosis and Haemostasis|October 4, 2002
Clinical use of a rapid collagen binding assay for von Willebrand factor cleaving protease in patients with thrombotic thrombocytopenic purpuraMargaret E Rick, Stephan Moll, Mark A Taylor, et al.The Annals of Pharmacotherapy|April 10, 2015
Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients Receiving Rivaroxaban: Can This Test Be Used to Quantify Drug Level?Robert C Gosselin, Suzanne J Francart, Emily M Hawes, et al.Journal of Thrombosis and Thrombolysis|February 27, 2007
Prospective study of supplemental vitamin K therapy in patients on oral anticoagulants with unstable international normalized ratiosSarah K Ford, Caron P Misita, Betsy Bryant Shilliday, et al.Journal of Thrombosis and Haemostasis : JTH|July 14, 2021
Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of AnticoagulationKarlyn A Martin, Jan Beyer-Westendorf, Bruce L Davidson, et al.Pageof 8